Effect of pergolide treatment on insulin dysregulation in horses and ponies with pituitary pars intermedia dysfunction
Pergolide had no effect on tissue insulin sensitivity. However, the results suggest that postprandial hyperinsulinaemia may be limited by this dopamine receptor agonist in animals with PPID plus ID.
Authors
- Tobias Warnken (ORCID: https://orcid.org/0000-0002-0741-4674)
- Patricia A. Harris (ORCID: https://orcid.org/0000-0003-4068-1624)
- Madison L. Erdody
- Martin N. Sillence (ORCID: https://orcid.org/0000-0003-2837-5456)
- Nicholas J. Bamford (ORCID: https://orcid.org/0000-0001-7675-9126)
- Simon Bailey (ORCID: https://orcid.org/0000-0001-9348-5497)
- Strachan Mackenzie (ORCID: https://orcid.org/0000-0002-9695-7127)
- Nicolas C. Galinelli (ORCID: https://orcid.org/0000-0002-5915-1159)
Institutions
- Boehringer Ingelheim (Germany) (DE)
- Queensland University of Technology (AU)
- The University of Melbourne (AU)
- Melton Mowbray Hospital (GB)
Publication Details
- Journal
- Equine Veterinary Journal
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1111/evj.14468
- Citations
- 5
- Primary Topic
- Veterinary Equine Medical Research
- Type
- article
- Field-Weighted Citation Impact
- 13.65
Funders
- Waltham Centre for Pet Nutrition
- Australian Research Council